MedKoo Cat#: 464855 | Name: ARN23746

Description:

WARNING: This product is for research use only, not for human or veterinary use.

ARN23746 is a potent and selective inhibitor of the Na⁺-K⁺-2Cl⁻ cotransporter 1 (NKCC1), a key regulator of intracellular chloride homeostasis and neuronal excitability. In biochemical assays, ARN23746 inhibits human NKCC1 with an IC₅₀ of approximately 2.1 µM, showing over 30-fold selectivity against NKCC2. In preclinical models, it effectively modulates GABAergic signaling by reducing intracellular Cl⁻ levels, thereby enhancing the inhibitory action of GABA. In vivo, ARN23746 crosses the blood–brain barrier and exhibits antiepileptic activity in rodent seizure models without affecting renal NKCC2-mediated function, suggesting a favorable therapeutic window for central nervous system disorders such as epilepsy or neurodevelopmental diseases involving altered chloride homeostasis.

Chemical Structure

ARN23746
CAS#2497525-96-7

Theoretical Analysis

MedKoo Cat#: 464855

Name: ARN23746

CAS#: 2497525-96-7

Chemical Formula: C17H25F3N2O4S

Exact Mass: 410.1487

Molecular Weight: 410.45

Elemental Analysis: C, 49.75; H, 6.14; F, 13.89; N, 6.83; O, 15.59; S, 7.81

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
ARN23746; ARN 23746; ARN-23746; IAMA-6
IUPAC/Chemical Name
3-(N,N-dimethylsulfamoyl)-4-((8,8,8-trifluorooctyl)amino)benzoic acid
InChi Key
ZAJDYPRGNPKHEI-UHFFFAOYSA-N
InChi Code
InChI=1S/C17H25F3N2O4S/c1-22(2)27(25,26)15-12-13(16(23)24)8-9-14(15)21-11-7-5-3-4-6-10-17(18,19)20/h8-9,12,21H,3-7,10-11H2,1-2H3,(H,23,24)
SMILES Code
O=C(O)C1=CC(S(=O)(N(C)C)=O)=C(NCCCCCCCC(F)(F)F)C=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 410.45 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Borgogno M, Savardi A, Manigrasso J, Turci A, Portioli C, Ottonello G, Bertozzi SM, Armirotti A, Contestabile A, Cancedda L, De Vivo M. Design, Synthesis, In Vitro and In Vivo Characterization of Selective NKCC1 Inhibitors for the Treatment of Core Symptoms in Down Syndrome. J Med Chem. 2021 Jun 17. doi: 10.1021/acs.jmedchem.1c00603. Epub ahead of print. PMID: 34137257. 2: Savardi A, Borgogno M, Narducci R, La Sala G, Ortega JA, Summa M, Armirotti A, Bertorelli R, Contestabile A, De Vivo M, Cancedda L. Discovery of a Small Molecule Drug Candidate for Selective NKCC1 Inhibition in Brain Disorders. Chem. 2020 Aug 6;6(8):2073-2096. doi: 10.1016/j.chempr.2020.06.017. PMID: 32818158; PMCID: PMC7427514.